WallStSmart

BrightSpring Health Services, Inc. Common Stock (BTSG)vsHealth Catalyst Inc (HCAT)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

BrightSpring Health Services, Inc. Common Stock generates 4411% more annual revenue ($13.65B vs $302.48M). BTSG leads profitability with a 2.3% profit margin vs -87.7%. BTSG earns a higher WallStSmart Score of 53/100 (C-).

BTSG

Buy

53

out of 100

Grade: C-

Growth: 8.7Profit: 5.5Value: 4.0Quality: 6.0
Piotroski: 5/9Altman Z: 2.59

HCAT

Avoid

34

out of 100

Grade: F

Growth: 3.3Profit: 2.0Value: 5.0Quality: 4.0
Piotroski: 3/9Altman Z: -3.47

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

BTSG2 strengths · Avg: 9.0/10
EPS GrowthGrowth
359.8%10/10

Earnings expanding 359.8% YoY

Revenue GrowthGrowth
25.6%8/10

Revenue surging 25.6% year-over-year

HCAT1 strengths · Avg: 10.0/10
Price/BookValuation
1.2x10/10

Reasonable price relative to book value

Areas to Watch

BTSG4 concerns · Avg: 2.8/10
Profit MarginProfitability
2.3%3/10

2.3% margin — thin

Operating MarginProfitability
3.4%3/10

Operating margin of 3.4%

Debt/EquityHealth
1.363/10

Elevated debt levels

P/E RatioValuation
90.1x2/10

Premium valuation, high expectations priced in

HCAT4 concerns · Avg: 3.3/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$153.70M3/10

Smaller company, higher risk/reward

Debt/EquityHealth
1.233/10

Elevated debt levels

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Comparative Analysis Report

WallStSmart Research

Bull Case : BTSG

The strongest argument for BTSG centers on EPS Growth, Revenue Growth. Revenue growth of 25.6% demonstrates continued momentum.

Bull Case : HCAT

The strongest argument for HCAT centers on Price/Book.

Bear Case : BTSG

The primary concerns for BTSG are Profit Margin, Operating Margin, Debt/Equity. A P/E of 90.1x leaves little room for execution misses. Thin 2.3% margins leave little buffer for downturns.

Bear Case : HCAT

The primary concerns for HCAT are EPS Growth, Market Cap, Debt/Equity.

Key Dynamics to Monitor

BTSG profiles as a growth stock while HCAT is a turnaround play — different risk/reward profiles.

BTSG carries more volatility with a beta of 1.79 — expect wider price swings.

BTSG is growing revenue faster at 25.6% — sustainability is the question.

BTSG generates stronger free cash flow (101M), providing more financial flexibility.

Bottom Line

BTSG scores higher overall (53/100 vs 34/100) and 25.6% revenue growth. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

BrightSpring Health Services, Inc. Common Stock

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

BrightSpring Health Services, Inc. (BTSG) is a leading provider of home and community-based health services, focusing on diverse patient populations, including individuals with intellectual and developmental disabilities and those in need of rehabilitation support. The company prioritizes personalized, high-quality care, facilitated by a dedicated and skilled workforce that significantly improves patient outcomes and quality of life. With robust investments in innovative technologies and a strong commitment to value-based care, BrightSpring is well-positioned to capitalize on growth opportunities within the dynamic healthcare landscape, highlighting its potential for sustainable, long-term success.

Visit Website →

Health Catalyst Inc

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. The company is headquartered in South Jordan, Utah.

Visit Website →

Want to dig deeper into these stocks?